Literature DB >> 22858650

On the armament and appearances of human myeloid-derived suppressor cells.

Isabel Poschke1, Rolf Kiessling.   

Abstract

Myeloid-derived suppressor cells (MDSC) have frequently been observed in patients with cancer. This heterogeneous population of myeloid cells can exert potent suppression of lymphocyte function and thereby poses a significant hurdle to natural or therapeutically induced anti-tumor immunity. On the other hand, the natural function of MDSC is not yet well understood and their role in infection, inflammation and autoimmune disease is still puzzling. Understanding MDSC biology will provide the tools necessary for therapeutic targeting of this population, but also permit exploitation of their strong tolerogenic function in the treatment of inflammatory conditions and the prevention of graft rejection.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22858650     DOI: 10.1016/j.clim.2012.06.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  76 in total

Review 1.  Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation.

Authors:  Joseph R Scalea; Young Suk Lee; Eduardo Davila; Jonathan S Bromberg
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

2.  Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.

Authors:  Shigehisa Kitano; Michael A Postow; Carly G K Ziegler; Deborah Kuk; Katherine S Panageas; Czrina Cortez; Teresa Rasalan; Mathew Adamow; Jianda Yuan; Philip Wong; Gregoire Altan-Bonnet; Jedd D Wolchok; Alexander M Lesokhin
Journal:  Cancer Immunol Res       Date:  2014-05-20       Impact factor: 11.151

3.  A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis.

Authors:  Smriti Sharma; Richard E Davis; Shweta Srivastva; Susanne Nylén; Shyam Sundar; Mary E Wilson
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

Review 4.  Advances in radiotherapy and targeted therapies for rectal cancer.

Authors:  Alexandra Sermeus; Wim Leonard; Benedikt Engels; Mark De Ridder
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 5.  Regulation of tumor metastasis by myeloid-derived suppressor cells.

Authors:  Thomas Condamine; Indu Ramachandran; Je-In Youn; Dmitry I Gabrilovich
Journal:  Annu Rev Med       Date:  2014-10-09       Impact factor: 13.739

6.  mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model.

Authors:  Adi Sharbi-Yunger; Mareike Grees; Esther Tzehoval; Jochen Utikal; Viktor Umansky; Lea Eisenbach
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

7.  MDSC and TGFβ Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes.

Authors:  Anna A Shvedova; Elena R Kisin; Naveena Yanamala; Alexey V Tkach; Dmitriy W Gutkin; Alexander Star; Galina V Shurin; Valerian E Kagan; Michael R Shurin
Journal:  Cancer Res       Date:  2015-03-05       Impact factor: 12.701

8.  Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.

Authors:  Pauline L de Goeje; Koen Bezemer; Marlies E Heuvers; Anne-Marie C Dingemans; Harry Jm Groen; Egbert F Smit; Henk C Hoogsteden; Rudi W Hendriks; Joachim Gjv Aerts; Joost Pjj Hegmans
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

9.  Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model.

Authors:  Erica N Bozeman; Ashley Cimino-Mathews; Deepa K Machiah; Jaina M Patel; Arun Krishnamoorthy; Linda Tien; Rangaiah Shashidharamurthy; Periasamy Selvaraj
Journal:  Vaccine       Date:  2013-03-28       Impact factor: 3.641

10.  In Vivo Mobilization and Functional Characterization of Nonhuman Primate Monocytic Myeloid-Derived Suppressor Cells.

Authors:  A F Zahorchak; M B Ezzelarab; L Lu; H R Turnquist; A W Thomson
Journal:  Am J Transplant       Date:  2015-09-15       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.